InfuSystems Holdings, Inc. (INFU) vs Standard BioTools Inc. (LAB)
InfuSystems Holdings, Inc. and Standard BioTools Inc. are both Medical Devices companies. Standard BioTools Inc. is the larger, with a market value of $291.7M against $252.8M — 1.2× the size. Standard BioTools Inc. trades at the lower P/E: 3.4× against 30.3×. Standard BioTools Inc. grew revenue faster over the last twelve months: 30.2% against 2.47%. Standard BioTools Inc. has the higher net margin (100.4% vs 5.96%) and the lower return on invested capital (−93.9% vs 10.6%). Across the 21 metrics below, Standard BioTools Inc. leads on 12 and InfuSystems Holdings, Inc. on 9.
Valuation
Profitability
| Metric | INFU | LAB | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.45% | 50.49% | 56.01% |
| Operating margin | 9.26% | (112.85%) | (15.03%) |
| Net margin | 5.96% | 100.37% | (20.40%) |
| Free cash flow margin | 10.56% | (97.61%) | (7.24%) |
| Return on equity | 15.03% | 17.61% | (15.32%) |
| Return on assets | 8.61% | 14.34% | (19.72%) |
| Return on invested capital | 10.55% | (93.89%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack